RELAPSE LEUKEMIA
Clinical trials for RELAPSE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSE LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo offers hope for Hard-to-Treat leukemias
Disease control Recruiting nowThis study tests whether combining two drugs, revumenib and mezigdomide, is safe for people with acute leukemias that have returned or not improved after prior treatment. The trial includes patients aged 12 and older with specific genetic changes (KMT2A-r, NUP98-r, or NPM1-m). Th…
Matched conditions: RELAPSE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New cell addback may shield kids from deadly infections after transplant
Disease control Recruiting nowThis study tests whether adding a special type of immune cell (memory T cells) after a stem cell transplant can help children fight off viral and fungal infections. About 100 children and young adults with blood cancers, immune disorders, or bone marrow failure will receive this …
Matched conditions: RELAPSE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Indian Children's genes may hold key to better leukemia care
Knowledge-focused Recruiting nowThis study follows 500 Indian children with acute lymphoblastic leukemia (ALL) to see how their genes influence treatment side effects and how well they respond to therapy. Researchers will collect blood samples and track health outcomes over five years. The goal is to personaliz…
Matched conditions: RELAPSE LEUKEMIA
Sponsor: University of Geneva, Switzerland • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:27 UTC